Healthpeak Properties Inc (N:DOC)
Business Focus: N/A
| Sector: N/A | Industry: N/A |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 4600 South Syracuse Street, Suite 500 DENVER CO 80237 |
| Tel: | 1-949-4070400 |
| Website: | https://www.healthpeak.com |
| IR: | See website |
| Key People | ||
| Scott M. Brinker President, Chief Executive Officer, Director | Peter A. Scott Chief Financial Officer | Thomas M. Klaritch Chief Operating Officer |
| Lisa A. Alonso Chief Human Resource Officer, Executive Vice President | Shawn G. Johnston Executive Vice President, Chief Accounting Officer | Ankit B. Patadia Executive Vice President and Treasurer - Corporate Finance |
| Adam G. Mabry Chief Investment Officer | Jeffrey H. Miller General Counsel | Scott R. Bohn Chief Development Officer and Co-Head of Life Science |
| Business Overview |
| Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company's segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians' offices and examination rooms. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Healthpeak Properties Inc revenues increased 6% to $2.18B. Net income applicable to common stockholders excluding extraordinary items decreased 39% to $304.3M. Revenues reflect Life Science segment increase of 7% to $878.3M, NAREIT FFO Per Share - Diluted - Total increase of 8% to $1.79. Net income was offset by Depreciation increase of 6% to $749.9M (expense). |
| Employees: | 193 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $19,517M as of Jan 31, 2024 |
| Annual revenue (TTM): | $2,181M as of Jan 31, 2024 |
| EBITDA (TTM): | $1,199M as of Jan 31, 2024 |
| Net annual income (TTM): | $304.28M as of Jan 31, 2024 |
| Free cash flow (TTM): | -$447.83M as of Jan 31, 2024 |
| Net Debt Last Fiscal Year: | $6,759M as of Jan 31, 2024 |
| Shares outstanding: | 709,577,429 as of Mar 5, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.